Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V D Schmith

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pharmacology|July 1, 1997
Dose proportionality of cisatracuriumV D Schmith, J Fiedler-Kelly, L Phillips, et al.
Journal of Clinical Pharmacology|June 1, 1991
Alprazolam in end-stage renal disease: I. PharmacokineticsV D Schmith, B Piraino, R B Smith, et al.
Journal of Chromatography|July 17, 1991
New high-performance liquid chromatographic method for the determination of alprazolam and its metabolites in serum: instability of 4-hydroxyalprazolamV D Schmith, S R Cox, M A Zemaitis, et al.
Journal of Clinical Pharmacology|March 1, 1996
The effects of epoprostenol on drug disposition. II: A pilot study of the pharmacokinetics of furosemide with and without epoprostenol in patients with congestive heart failureL D Carlton, J H Patterson, C N Mattson, et al.
Journal of Clinical Pharmacology|March 1, 1996
The effects of epoprostenol on drug disposition. I: A pilot study of the pharmacokinetics of digoxin with and without epoprostenol in patients with congestive heart failureL D Carlton, J H Patterson, C N Mattson, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 7, 2014
Population pharmacokinetics of azithromycin in whole blood, peripheral blood mononuclear cells, and polymorphonuclear cells in healthy adultsM R Sampson, T P Dumitrescu, K L R Brouwer, et al.
Clinical Pharmacology and Therapeutics|November 11, 1992
Population pharmacodynamics of doxacuriumV D Schmith, J Fiedler-Kelly, M Abou-Donia, et al.
Anesthesiology|February 1, 1996
Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesiaC A Lien, V D Schmith, M R Belmont, et al.
Anesthesia and Analgesia|November 1, 1996
Importance of the organ-independent elimination of cisatracuriumD F Kisor, V D Schmith, W A Wargin, et al.
Anesthesiology|June 1, 1994
The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesiaC A Lien, V D Schmith, P B Embree, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacology|July 1, 1997
Dose proportionality of cisatracuriumV D Schmith, J Fiedler-Kelly, L Phillips, et al.
Journal of Clinical Pharmacology|June 1, 1991
Alprazolam in end-stage renal disease: I. PharmacokineticsV D Schmith, B Piraino, R B Smith, et al.
Journal of Chromatography|July 17, 1991
New high-performance liquid chromatographic method for the determination of alprazolam and its metabolites in serum: instability of 4-hydroxyalprazolamV D Schmith, S R Cox, M A Zemaitis, et al.
Journal of Clinical Pharmacology|March 1, 1996
The effects of epoprostenol on drug disposition. II: A pilot study of the pharmacokinetics of furosemide with and without epoprostenol in patients with congestive heart failureL D Carlton, J H Patterson, C N Mattson, et al.
Journal of Clinical Pharmacology|March 1, 1996
The effects of epoprostenol on drug disposition. I: A pilot study of the pharmacokinetics of digoxin with and without epoprostenol in patients with congestive heart failureL D Carlton, J H Patterson, C N Mattson, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 7, 2014
Population pharmacokinetics of azithromycin in whole blood, peripheral blood mononuclear cells, and polymorphonuclear cells in healthy adultsM R Sampson, T P Dumitrescu, K L R Brouwer, et al.
Clinical Pharmacology and Therapeutics|November 11, 1992
Population pharmacodynamics of doxacuriumV D Schmith, J Fiedler-Kelly, M Abou-Donia, et al.
Anesthesiology|February 1, 1996
Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesiaC A Lien, V D Schmith, M R Belmont, et al.
Anesthesia and Analgesia|November 1, 1996
Importance of the organ-independent elimination of cisatracuriumD F Kisor, V D Schmith, W A Wargin, et al.
Anesthesiology|June 1, 1994
The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesiaC A Lien, V D Schmith, P B Embree, et al.
Pageof 3